Metabolic activation of benzo[c]phenanthrene by cytochrome P450 enzymes in human liver and lung

Chemical Research in Toxicology

Volumn 14, Issue 6, 2001, Pages 686-693

  Baum, M ^a   Amin, S ^a,b   Guengerich, F P ^a,c   Hecht, S S ^a,d   Kohl W ^a   Eisenbrand, G ^a  

^a France   (Germany)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; BENZO[C]PHENANTHRENE; BENZO[C]PHENANTHRENE 3,4 DIHYDRODIOL; BENZO[C]PHENANTHRENE 3,4 DIHYDRODIOL 1,2 EPOXIDE; BENZO[C]PHENANTHRENE 5,6 DIHYDRODIOL; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 INHIBITOR; EPOXIDE; MICROSOME ENZYME; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC COMPOUND; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CARCINOGENESIS; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIVER MICROSOME; METABOLISM; METABOLITE; PROTEIN EXPRESSION;

EID: 0034978878     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000240s     Document Type: Article

References (56)

1. Polycyclic aromatic hydrocarbons in Dutch total diet samples (1984-1986)
2. Carcinogenic polycyclic aromatic hydrocarbons in Norwegian smoked meet sausages
3. Exceptionally high tumor-initiating activity of benzo[c]phenanthrene bay-region diol-epoxides on mouse skin
4. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo[c]phenanthrene in murine tumor models
5. The production of cancer by pure hydrocarbon
6. Carcinogenicity of benzo[a]anthracene and benzo[c]phenanthrene derivates
7. Mutagenicity of the dihydrodiols and bay-region diolepoxides of benzo[c]phenanthrene in bacterial and mammalian cells
8. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo[c]phenanthrene 3,4-diol-l,2-epoxides in bacterial and mammalian cells
9. Benzo[c]phenanthrene-DNA-adducts in mouse epidermis in relation to the tumorigenicities of four configurationally isomeric 3,4-dihydrodiol 1,2-epoxides
10. Benzo[c]phenanthrene 3,4-dihydrodiol 1,2-epoxide adducts in native and denaturated DNA
11. Stereochemical specificity in the metabolic activation of benzo[c]phenanthrene to metabolites that bind to DNA in rodent embryo cell cultures
12. Tumor-initiating activity on mouse skin of bay region diol-epoxides of 5,6-dimethylchrysene and benzo[c]phenanthrene
13. Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene
14. Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,1]pyrene
15. Metabolism of benzo[c]phenanthrene by rat liver microsomes and by a purified monooxygenase system reconstituted with different isoenzymes of cytochrome P450
16. Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skin
17. Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis
18. Regio- and stereoselectivity in the metabolism of benzo[c]phenanthrene mediated by genetically engineered V79 Chinese hamster cells expressing human cytochromes P450
19. An improved synthesis of antibenzo[c]phenanthrene-3,4-diol-l,2-epoxide via 4-methoxybenzo[c]phenanthrene
20. Synthesis of benzo[c]phenanthrene dihydrodiols
21. Analysis and characterization of enzymes
22. Interlaboratory comparison of total cytochrome P450 and protein determinations in rat liver microsomes
23. Determination of drug metabolizing enzymes in needle biopsies of human liver
24. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450-enzymes
25. Activation of amino-α-2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P450-enzymes in rat and human liver-microsomes
26. Drug metabolism by Escherichia coli expressing human cytochromes P450
27. 17β-estradiol hydroxylation catalized by human cytochrome P450 1B1
28. SOS function tests for studies of chemical carcinogenesis using Salmonella typhimurium TA 1535/pSK 1002, NM 2009, and NM3009
29. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009)
30. Human liver microsomal cytochrome P450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002
31. Use of the newly developed tester strain Salmonella typhimurium NM 2009 for the study of metabolic activation to carcinogenic aromatic amines by rat liver microsomal cytochrome P450 enzymes
32. Cytochrome P450-mediated activation of procarcinogens and promutagens of DNA-damaging products by measuring expression of umu-gene in Salmonella typhimurium TA 1535/pSK1002
33. Metabolic activation of chrysene by human hepatic and pulmonary cytochrome P450 enzymes
34. DNA adduct formation in mouse tissues in relation to serum levels of benzo[a]pyrenediol-epoxides after injection of benzo[a]pyrene or the diol-epoxide
35. Comparative metabolism of the tobacco related carcinogens benzo[a]pyrene, 4-methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N′-nitrosonornicotine in human hepatic microsomes
36. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes
37. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi
38. Roles of individual human cytochrome P450-enzymes in the bioactivation of benzo[a]pyrene, 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, and other dihydrodiol derivates of polycyclic aromatic hydrocarbons
39. Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo[a]pyrene
40. Human cytochrome P450s
41. 1 by bacterial recombinant human cytochrome P450 enzymes
42. 1 to mutagens in human liver
43. 1 metabolism in human liver microsomes by naturally occurring flavonoids
44. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides
45. Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P450 isozymes from rabbit liver microsomes
46. Activation of CYP 3A4: Evidence for the simultaneous binding of the two substrates in a cytochrome P450 active site
47. Expression of CYP 1B1 in human adult and fetal tissues and differential inducibility of CYP 1B1 and CYP 1A1 by Ah receptor ligands in human placenta and cultured cells
48. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
49. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays
50. Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food derived heterocyclic amine mutagens by human cytochromes P450
51. Catalytic activities of human liver cytochrome P450 IIIA4 expressed in Saccharomyces cerevisiae
52. The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen